Table 2.
Campaign and diabetes-specific characteristics with the Fisher exact test to examine contributors to the funding status (N=205, unless otherwise specified).
| Variable | Fully funded (n=22), n (%) | Not funded (n=183), n (%) | Total (N=205), n (%) | P (Fisher exact test) | |||||
| Type of diabetes |
|
|
|
N/Aa,b | |||||
|
|
Type 1 or latent autoimmune diabetes in adults | 10 (46) | 84 (46) | 94 (46) |
|
||||
|
|
Type 2 | 2 (9) | 17 (9) | 19 (9) |
|
||||
|
|
Gestational | 0 (0) | 2 (1) | 2 (0) |
|
||||
|
|
Unknown | 10 (46) | 80 (44) | 90 (44) |
|
||||
| Reason for request |
|
|
|
N/A | |||||
|
|
Insurance/system issue (uninsured, underinsured) | 12 (55) | 113 (62) | 125 (61) |
|
||||
|
|
Personal issue (loss of job, emergency) | 1 (5) | 10 (6) | 11 (5) |
|
||||
|
|
General fundraiser | 8 (26) | 41 (22) | 49 (24) |
|
||||
|
|
Insurance/system and personal issue | 1 (5) | 19 (10) | 20 (10) |
|
||||
| Insulin typec |
|
|
|
N/A | |||||
|
|
Fast-acting (Apidra, Admelog, Fiasp, Afrezza) | 2 (9) | 50 (23) | 52 (21) |
|
||||
|
|
Long-acting (Lantus, Levemir, Basaglar, Toujeo, Tresiba) | 2 (9) | 39 (18) | 41 (17) |
|
||||
|
|
Intermediate/mixed/regular (neutral protamine hagedorn insulin [NPH], insulin regular human [R]) | 0 (0) | 15 (7) | 15 (6) |
|
||||
|
|
Concentrated (Humalog U200, U500) | 1 (4) | 3 (1) | 4 (2) |
|
||||
|
|
Other | 0 (0) | 1 (1) | 1 (0) |
|
||||
|
|
Unknown | 18 (78) | 114 (51) | 132 (54) |
|
||||
| Insulin requests |
|
|
|
N/A | |||||
|
|
One or more types requested | 4 (18) | 69 (38) | 73 (36) |
|
||||
|
|
Unknown | 18 (81) | 114 (62) | 132 (64) |
|
||||
| Medicare donut |
|
|
|
.74 | |||||
|
|
Yes | 3 (14) | 22 (12) | 25 (12) |
|
||||
|
|
No or not mentioned | 19 (86) | 161 (88) | 180 (88) |
|
||||
| Disability status |
|
|
|
>.99 | |||||
|
|
Yes | 2 (9) | 16 (9) | 18 (9) |
|
||||
|
|
No or not mentioned | 20 (91) | 167 (91) | 187 (91) |
|
||||
| Pharma supportd |
|
|
|
N/A | |||||
|
|
Requested and rejected | 1 (5) | 9 (5) | 10 (5) |
|
||||
|
|
Not mentioned (unknown) | 21 (96) | 174 (95) | 19 (95) |
|
||||
| Request amount |
|
|
|
.007 | |||||
|
|
≤US $500 | 9 (41) | 28 (15) | 22 (11) |
|
||||
|
|
>US $500 | 13 (59) | 155 (85) | 183 (89) |
|
||||
| Funding length |
|
|
|
.82 | |||||
|
|
<3 months | 7 (32) | 68 (37) | 75 (37) |
|
||||
|
|
≥3 months | 15 (68) | 116 (63) | 130 (63) |
|
||||
aN/A: not applicable.
bDid not analyze with the Fisher exact test owing to more than 20% missing data.
cFor this variable, the N values for fully funded, not funded, and total were 23, 222, and 245, respectively.
dN is >205, as some requests were more than one.